IPOPI JOSE DRABWELL RESEARCH GRANT PROGRAMME
Empowering Immunodeficiency Research Worldwide
Are you motivated to advance scientific and clinical research in immunodeficiencies? Take advantage of the IPOPI Research Grant Programme. Submit your proposal today for a chance to secure one of three 10,000 euros grants!
📝 Please familiarise yourself with the application guidelines before completing the form.
Scope:
The IPOPI Research Grant Programme is an initiative to promote scientific and clinical research in the field of primary immunodeficiencies and associated conditions. As the field is rapidly evolving, IPOPI believes it is key to stimulate ongoing and novel research efforts to continuously improve healthcare and patient quality of life. Discover the remarkable legacy of Jose Drabwell — find out more here.
Projects should be patient-centred and knowledge-generating.
A broad set of topics and disciplines may be considered, ranging from fundamental to clinical research or patient-derived studies, as well as medical anthropology, health economics, ethics, etc.
Who can apply: In keeping with IPOPI’s global reach, the application will be open to researchers, clinicians, nurses and other healthcare professionals (HCP), as well as patient organisations worldwide, with applicants from low- and middle-income countries (LMIC) being strongly encouraged to apply.
Funding: Grants will be based on project milestones and needs. IPOPI aims to fund 3 projects with grants of €10,000 per project.
Timeframe: All projects should be concluded within 2 years.
Evaluation: Proposals will undergo rigorous evaluation by the IPOPI review committee based on the following criteria:
- Patients – Centredness
- Innovation and Impact
- Budget Appropriateness
- Clear Milestones
- Feasibility
- Opportunity for Outcome Communication
- Project Sustainability
How to Apply: Interested applicants can find more details on the application process and conditions on our Application Guidelines page, from which applicants can also access the application form.
Key Dates
- Application Deadline: August 31, 2026
- Results Announced: October 1, 2026
Outcome and Follow-up: Selected projects will receive support throughout the research process, with opportunities for dissemination through IPOPI channels.
Ready to make a difference in the field of immunodeficiencies? Apply now, and let’s drive PID research forward together!



